Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer
Qiongjie Yu,* Xuedan Du,* Zhen Fang, Xiaolu Mao, Jinting Wu, Bin Wang, Wenfeng Li Department of Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: W...
Saved in:
| Main Authors: | Yu Q, Du X, Fang Z, Mao X, Wu J, Wang B, Li W |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f02616ec586c424f8e886a3043d0322e |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy
by: Hui Yang, et al.
Published: (2021) -
Identification and Validation of an Immune and Ferroptosis-Combined Index for Non–Small Cell Lung Cancer
by: Yang Teng, et al.
Published: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
by: Maja Šutić, et al.
Published: (2021) -
Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population
by: Adonis,Marta I, et al.
Published: (2014) -
MTA1 Expression Can Stratify the Risk of Patients with Multifocal Non-Small Cell Lung Cancers ≤3 cm
by: Wang W, et al.
Published: (2021)